Clinical value of FDG Hybrid-PET in staging and restaging of malignant lymphoma – compared with conventional diagnostic methods
| Autor: | Hatzl-Griesenhofer M, W. Maschek, H. Huber, G. Wahl, M. Fridrik, G. Wimmer, R. Pichler |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
medicine.medical_specialty
Diagnostic methods medicine.diagnostic_test business.industry Ultrasound Retrospective cohort study General Medicine medicine.disease Lymphoma law.invention Malignant lymphoma medicine.anatomical_structure law Biopsy Medicine Radiology Nuclear Medicine and imaging Radiology business Nuclear medicine Lymph node Gamma camera |
| Zdroj: | Nuklearmedizin. 39:166-173 |
| ISSN: | 2567-6407 0029-5566 |
| Popis: | Summary Aim of the present retrospective study was to validate the clinical value of F-18-FDG PET imaging in lymphoma patients with a dual head camera modified for coincidence detection. Staging before and after oncological treatment was compared with a conservative diagnostic approach. Methods: 48 patients (28 non-Hodgkin lymphoma, 20 Hodgkin’s disease) received FDG-Hybrid-PET scans. Pretherapeutic staging was realized in 28 patients, 9 of them had control studies after they had completed therapy. Totally 29 persons were examined for posttherapeutic restaging. Computed tomography imaging and lymph node sonography was performed in all cases. Results were validated by clinical follow-up, in three cases a récidivé was proven by biopsy. Results: CT and ultrasound detected 77 lesions in 28 patients compared with 100 visualized by PET, but this difference in pretherapeutic staging did not reach significance at p >0.05 by Fisher’s t-test. Hybrid-PET obtained a sensitivity of 93%, a specifity of 79%, a positive of 82% and a negative predictive value of 92% for detection of residual disease. The values for CT + US were 87%, 64%, 72% and 88% respectively. Conclusion: FDG Hybrid-PET is as or even more accurate than standard morphologic diagnostic methods for prestaging in malignant lymphoma. Additionally, there is a substancial benefit for therapy monitoring of residual disease using coincidence detection PET with a ¾-inch crystal gamma camera. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|